Minireviews
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Mar 18, 2022; 12(3): 42-54
Published online Mar 18, 2022. doi: 10.5500/wjt.v12.i3.42
New onset hypertension after transplantation
Mahmoud Nassar, Nso Nso, Sofia Lakhdar, Ravali Kondaveeti, Chandan Buttar, Harangad Bhangoo, Mahmoud Awad, Naveen Siddique Sheikh, Karim M Soliman, Most Sirajum Munira, Farshid Radparvar, Vincent Rizzo, Ahmed Daoud
Mahmoud Nassar, Nso Nso, Sofia Lakhdar, Ravali Kondaveeti, Chandan Buttar, Harangad Bhangoo, Vincent Rizzo, Department of Medicine, Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals: Queens), New York, NY 11432, United States
Mahmoud Awad, Department of Medicine, The Memorial Souad Kafafi University Hospital, 6th of October - Giza 0000, Egypt
Naveen Siddique Sheikh, Department of Physiology, CMH Lahore Medical College and Institute of Dentistry, Lahore - Punjab 0000, Pakistan
Karim M Soliman, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, United States
Most Sirajum Munira, Farshid Radparvar, Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals: Queens), New York, NY 11432, United States
Ahmed Daoud, Department of Medicine, Kasr Alainy Medical School, Cairo University, Cairo 11211, Egypt
Author contributions: All authors contributed equally in writing, editing, and reviewing the manuscript of the article.
Conflict-of-interest statement: The authors declare that there is no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ahmed Daoud, MBChB, MD, MSc, PhD, Lecturer, Staff Physician, Department of Medicine, Kasr Alainy Medical School, Cairo University, Kasr Alainy Street, Cairo 11211, Egypt. ahmed.daoud84@yahoo.com
Received: June 7, 2021
Peer-review started: June 7, 2021
First decision: July 28, 2021
Revised: August 14, 2021
Accepted: February 19, 2022
Article in press: February 19, 2022
Published online: March 18, 2022
Processing time: 284 Days and 1.3 Hours
Abstract

It has been reported that up to 90% of organ transplant recipients have suboptimal blood pressure control. Uncontrolled hypertension is a well-known culprit of cardiovascular and overall morbidity and mortality. In addition, rigorous control of hypertension after organ transplantation is a crucial factor in prolonging graft survival. Nevertheless, hypertension after organ transplantation encompasses a broader range of causes than those identified in non-organ transplant patients. Hence, specific management awareness of those factors is mandated. An in-depth understanding of hypertension after organ transplantation remains a debatable issue that necessitates further clarification. This article provides a comprehensive review of the prevalence, risk factors, etiology, complications, prevention, and management of hypertension after organ transplantation.

Keywords: New onset; Hypertension; Organ; Transplantation; Renal

Core Tip: This article provides a comprehensive review of the prevalence, risk factors, etiology, complications, prevention and management of hypertension after organ transplantation.